OA09121A - Nouveau sel de strontium, son procédé de préparation et les compositions pharmaceutiques le renfermant. - Google Patents

Nouveau sel de strontium, son procédé de préparation et les compositions pharmaceutiques le renfermant.

Info

Publication number
OA09121A
OA09121A OA59600A OA59600A OA09121A OA 09121 A OA09121 A OA 09121A OA 59600 A OA59600 A OA 59600A OA 59600 A OA59600 A OA 59600A OA 09121 A OA09121 A OA 09121A
Authority
OA
OAPI
Prior art keywords
pharmaceutical compositions
preparation process
compositions containing
strontium salt
new
Prior art date
Application number
OA59600A
Other languages
English (en)
French (fr)
Inventor
Wierzbicki Michel
Bonnet Jacqueline
Tsouderos Yannis
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of OA09121A publication Critical patent/OA09121A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Cephalosporin Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Light Receiving Elements (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
OA59600A 1988-06-29 1989-06-28 Nouveau sel de strontium, son procédé de préparation et les compositions pharmaceutiques le renfermant. OA09121A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8808729A FR2633619B1 (fr) 1988-06-29 1988-06-29 Nouveau sel de strontium, son procede de preparation et les compositions pharmaceutiques le renfermant

Publications (1)

Publication Number Publication Date
OA09121A true OA09121A (fr) 1991-10-31

Family

ID=9367847

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59600A OA09121A (fr) 1988-06-29 1989-06-28 Nouveau sel de strontium, son procédé de préparation et les compositions pharmaceutiques le renfermant.

Country Status (16)

Country Link
US (1) US4939164A (el)
EP (1) EP0349432B1 (el)
JP (1) JPH0248567A (el)
AT (1) ATE81118T1 (el)
AU (1) AU613297B2 (el)
CA (1) CA1312333C (el)
DE (1) DE68903059T2 (el)
DK (1) DK325289A (el)
ES (1) ES2044170T3 (el)
FR (1) FR2633619B1 (el)
GR (1) GR3006674T3 (el)
IE (1) IE64112B1 (el)
NZ (1) NZ229760A (el)
OA (1) OA09121A (el)
PT (1) PT91006B (el)
ZA (1) ZA894945B (el)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7404967B2 (en) * 1994-12-21 2008-07-29 Cosmederm, Inc. Topical product formulations containing strontium for reducing skin irritation
FR2749759B1 (fr) * 1996-06-17 1999-11-26 Adir Utilisation de sels de strontium pour l'obtention de compositions pharmaceutiques destinees au traitement de l'arthrose
CA2524610C (en) * 2003-05-07 2014-03-25 Osteologix A/S Strontium combinations for prophylaxis/treatment of cartilage and/or bone conditions
AU2004237439B2 (en) * 2003-05-07 2009-09-10 Osteologix A/S Treating cartilage/bone conditions with water-soluble strontium salts
AU2005216596B2 (en) * 2004-02-26 2011-03-24 Osteologix A/S Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions
ATE443541T1 (de) 2004-06-25 2009-10-15 Strontin Aps Zusammensetzungen mit strontium und vitamin d und ihre verwendungen
US7875627B2 (en) * 2004-12-07 2011-01-25 Abbott Laboratories Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (VR1) and uses thereof
EP2530068A1 (en) 2011-05-31 2012-12-05 Lacer, S.A. New strontium salts, synthesis and use thereof in the treatment of osteoporosis
EP3207188A1 (en) 2014-10-14 2017-08-23 Unilever NV Device for spraying an enclosure triggered by inclination of a rotatable lid
EP3206803A1 (en) 2014-10-14 2017-08-23 Unilever NV Spraying device

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2954384A (en) * 1960-09-27 Method for preparing kainic acid and its
DE3127275A1 (de) * 1980-12-11 1983-01-27 Leskovar, Peter, Dr.-Ing., 8000 München "harnsteinaufloesende mittel"

Also Published As

Publication number Publication date
CA1312333C (fr) 1993-01-05
PT91006B (pt) 1994-11-30
FR2633619B1 (fr) 1991-02-08
EP0349432A1 (fr) 1990-01-03
ATE81118T1 (de) 1992-10-15
IE892094L (en) 1989-12-29
GR3006674T3 (el) 1993-06-30
ES2044170T3 (es) 1994-01-01
FR2633619A1 (fr) 1990-01-05
ZA894945B (en) 1990-03-28
NZ229760A (en) 1991-06-25
JPH0248567A (ja) 1990-02-19
DE68903059D1 (de) 1992-11-05
JPH0587064B2 (el) 1993-12-15
DK325289D0 (da) 1989-06-29
AU3709289A (en) 1990-01-04
DK325289A (da) 1989-12-30
PT91006A (pt) 1989-12-29
US4939164A (en) 1990-07-03
EP0349432B1 (fr) 1992-09-30
DE68903059T2 (de) 1993-04-29
IE64112B1 (en) 1995-07-12
AU613297B2 (en) 1991-07-25

Similar Documents

Publication Publication Date Title
ZA848369B (en) Pharmaceutical compositions containing bilobalid for the treatment of neuropathies
ES530046A0 (es) Procedimiento para la obtencion de acidos quinoloncarboxilicos
NZ228130A (en) Therapeutic composition comprising fenofibrate and a solid surfactant which has been co-micronised; preparatory process
FR2670491B1 (fr) Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les renfermant.
NO890259L (no) Fremgangsmaate for fremstilling av terapeutisk aktive etylfenoksyacetamider.
EP0376251A3 (en) An anticoagulant substance obtained from urine
SE7902742L (sv) Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav
OA09121A (fr) Nouveau sel de strontium, son procédé de préparation et les compositions pharmaceutiques le renfermant.
IL88971A (en) Disubstituted pyridines, process and intermediates, their preparation and pharmaceutical compositions containing them
SE8703632L (sv) For fordrojd frigivning anordnad fluoridkomposition
ES2054089T3 (es) Formulaciones orales liquidas.
NO810480L (no) Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater
ZA875847B (en) Pharmaceutical compositions for the treatment of occlusive vascular diseases
JPS5545681A (en) 88chloroo66hydroxyy55methylbenzoic acid derivative
PT87634A (pt) Process for the preparation of pharmaceutical compositions containing n-imidazolyl derivatives of bicyclic compounds useful for the treatment of nephrophies
FR2600256B1 (fr) Medicament et composition medicamenteuse pour le traitement des tumeurs ainsi que pour le traitement des maladies infectieuses dues aux virus
DE3162277D1 (en) N-(4-phenyl-2-thiazolyl)-oxamidic-acid-2-ethoxyethylester, process for its preparation and pharmaceutical compositions containing this compound
HUT50633A (en) Process for producing pharmaceutical compositions comprising 1,4-dihydropyridine derivatives
YU262380A (en) Process for obtaining piperidine derivatives of 4,5-dialkyl-3-hydroxy-pyrrol-2-carboxylic acid
DK0538690T3 (da) Arylquinolyl-substituerede 1,4-dihydropyridin-dicarboxylsyrederivater, fremgangsmåde til deres fremstilling af deres anvendelse i lægemidler
ATA67688A (de) Neue 3-(2-haloalkyl)-1,4-oxathiine und 2-(2-halo- alkyl)-1,4-dithiine sowie pharmazeutische zusammensetzungen mit diesen verbindungen zur behandlung von leukaemie und tumoren
HU895238D0 (en) Process for the preparation of pharmaceutical composition suitable for the treatment of pyogenous skin diseases
HU895239D0 (en) Process for the preparation of pharmaceutical compositions suitable for the treatment of skin diseases
HU213268B (en) Process for producing pharmaceutical composition for treating dermatological diseases
FR2328477A1 (fr) Medicament pour le traitement d'affections des muqueuses, en particulier des maladies parodontales